Tight control of rheumatoid arthritis (RA) disease activity requires frequent disease monitoring and adjustment of therapy, as often as every 3 to 6 months. Unfortunately, the American College of Rheumatology (ACR) recommendations are sometimes not followed in clinical practice, particularly the use of disease activity measures, the application of treat-to-target recommendations, and the implementation of ACR treatment algorithms, leading to suboptimal patient care. This series of patient visit scenarios will allow you to make management decisions, benchmark your scores against those of your peers, and hear from experts in the field.
Upon completion of this activity, participants should be better able to:
William J. Koopman Endowed Professor, Rheumatology and Immunology
Director, UAB Arthritis Clinical Intervention Program
Co-Director, UAB Center for Education and Research on Therapeutics
(CERTS) of Musculoskeletal Disorders
Co-Director, UAB PharmacoEpidEmiology and phaRmcoeconomics (PEER) Unit
University of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology
Birmingham, AL
Clinical Associate Professor, Medicine
Drexel University School of Medicine
Philadelphia, PA
Assistant Professor, Division of General Internal Medicine
Hospital for Special Surgery
Division of Rheumatology
Weill Cornell Medicine
New York, NY
Featured RMEI CE Activities – Earn CE Credit(s)
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources